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Abstract 
 
Background and Purpose 
 
Aneurysmal subarachnoid haemorrhage (SAH) is characterized by important changes 
in the autonomic nervous system (ANS) with potential adverse consequences. The 
baroreflex has a key role in regulating ANS. Its role in SAH outcome is not known.  
The purpose of this study was to evaluate the association between the baroreflex and 
the functional 3-month outcome in SAH. 
  
 
Methods 
The study used a prospective database of 101 patients hospitalized for SAH. We 
excluded patients receiving beta-blockers or noradrenaline. Baroreflex sensitivity (BRS) 
was measured using the cross-correlation method. A good outcome was defined by a 
Glasgow Outcome Score (GOS) at 4 or 5 at 3 months. 
 
Results 
Fourty-eight patients were included. Median age was 58 years old (36 to 76); F/M: 
34/14. The WFNS clinical severity score upon admission was 1 or 2 for 73% of patients. 
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In the univariate analysis, BRS (P=0.007), sedation (P=0.001), WFNS score (P=0.001), 
Glasgow score (P=0.002), Fisher score (P=0.022) and heart rate (P=0.037) were 
associated with outcome. The area under the curve (AUC) for the model with BRS as 
single predictor was estimated at 0.835. For each unit increase in BRS, the odds for a 
good outcome were predicted to increase by 31%. AUC for heart rate alone was 0.670.  
In the multivariate analysis, BRS (OR: 1.312[1.048-1.818]; P=0.018) and WFNS (OR: 
0.382[0.171-0.706]; P=0.001) were significantly associated with outcome. AUC was 
estimated at 0.900. 
 
Conclusions 
In SAH, early BRS was associated with 3-month outcome. This conclusion requires 
confirmation on a larger number of patients in a multicentre study. 
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Introduction 
 
Aneurysmal subarachnoid haemorrhage is associated with a level of mortality varying 
from 32% to 67% and with incapacitating consequences in 30% of cases (1). 
Patients’ outcome relates, on the one hand, to the occurrence of a delayed ischemic 
deficit and, on the other hand, to the occurrence of systemic, in particular cardiac, 
complications (2). Progress has been made in the treatment and prevention of 
delayed ischemic deficit (DID) over the last decade, in particular through the 
management of severe vasospasm and assessment of cerebral autoregulation when 
available. Systemic complications are mainly cardiovascular, particularly the 
occurrence of arrhythmia, myocardial ischemia or Tako Tsubo cardiomyopathy 
characterized by a modification of cardiac contractility under the effect of activation 
of the sympathetic system (3). These complications are difficult to predict and 
prevent, especially in the case of intubated, sedated patients. Hence the concern to 
search for warning signs that may precede aggravation, in particular in intensive care 
units. 
The arterial baroreflex behaves like a marker of a healthy cardiovascular autonomic 
nervous system. Its role is to maintain the cardiovascular homeostasis in order to 
cope with physiological and pathological changes. The baroreflex is a biofeedback 
loop where changes in the heart rate occur in response to the variations of blood 
pressure with a decrease in heart rate when blood pressure increases and vice-versa. 
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Its function is measured as a variation in milliseconds (ms) of the R-R interval 
between two pulse beats, for each unit of variation in the same direction of systolic 
blood pressure (sABP) in mmHg. It is expressed as a slope of interval versus sABP 
regression line, given in msec/mmHg, known as baroreflex sensitivity (BRS). 
The activation of the sympathetic system has been associated with baroreflex 
impairment (4 , 5, 6).  
Baroreflex impairement was associated with a poor outcome after a myocardial 
infarction (7). It was also associated with the severity of coronary lesions (8) and also 
with ischemic stroke (9). In ischemic and haemorrhagic stroke (10, 11), BRS 
diminution was associated with an unfavourable  outcome. 
Two other determinants of baroreflex diminution are age (5, 12), and carotid 
atherosclerosis (13, 6, 14-16).  
Currently, multicentre trials are being carried out to evaluate the therapeutic impact 
of baroreflex stimulation in resistant hypertension and in heart failure. 
Subarachnoid haemorrhage is a situation that can be seen as a cataclysmic activation 
of the stress system with deleterious effects which are well known by the 
neurointensivists who manage these patients. In subarachnoid haemorrhage, scarce 
data is available we do not have any data concerning the association between 
baroreflex changes and the outcome (17, 18). A previous study (published as an 
abstract) showed that an early and significantly reduced BRS is observed in SAH 
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patients that develop vasospasm, while BRS changes did not correlate to clinical 
outcome assessed by extended Glasgow Outcome Scale (17). Another study in 20 
brain-injured patients, including 3 patients with SAH, showed that an altered 
baroreflex function correlated with unfavourable outcome in these patients (18) 
Investigating the association between BRS and outcome in a population of SAH 
patients can be particularly useful for the identification of high-risk patients, 
especially sedated ventilated patients who cannot be clinically monitored. 
The main objective of this single center study was to assess the association between 
baroreflex sensitivity on admission and the 3 month outcome in aneurysmal 
subarachnoid haemorrhage. 
Methods 
 
The manuscript adheres to the AHA Journals' implementation of the Transparency 
and Openness Promotion (TOP) Guidelines. The data that support the findings of this 
study are available from the corresponding author upon reasonable request 
 
Population 
This study is based on the data collected from a prospective series of 101 patients 
admitted at the teaching hospital Addenbrooke of Cambridge (UK) in the 
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Neuroscience Department for aneurysmal rupture subarachnoid haemorrhage, 
between June 2010 and January 2012. This series had been initially studied to predict 
the occurrence of delayed ischemic deficit in these patients, based on the early 
changes of cerebral autoregulation (19). 
Inclusion criteria were as follows: ≥18 years of age; aneurysmal subarachnoid 
haemorrhage confirmed with either computed tomography angiography (CTA) or 
digital subtraction angiography (DSA); <5 days elapsed from the occurrence of 
subarachnoid haemorrhage.  
Patients were treated according to current guidelines (20,21). Initial management 
included prompt cardiopulmonary support (if required), maintenance of euvolemia, 
oral nimodipine 60mg every 4 hours, and treatment of acute hydrocephalus with 
external ventricular drainage (if required). The decision to treat by surgical clipping or 
endovascular embolization was performed on the basis of consensus between a team 
of neurosurgeons and interventional radiologists. (19). When patients were sedated, 
propofol and at least one of the following drugs: fentanyl, remifentanyl and 
midazolam, were used. 
The exclusion criteria which we have identified for this study are the treatment with 
beta-blockers or with a sympathomimetic agent such as noradrenaline, as practiced 
in intensive care units to increase blood pressure in patients with vasospasm. These 
patients were excluded because beta-blockers or sympathomimetic agents may alter 
the baroreflex sensitivity (BRS). 
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All patients underwent multimodal neuromonitoring  including  arterial blood 
pressure (ABP) monitoring for at least 30 minutes per session. Where available, ABP 
was monitored from the radial artery using a pressure monitoring kit (Baxter 
Healthcare, CA). Otherwise, ABP was monitored noninvasively with 
photoplethysmography (Finapress 2300  - Ohmeda, The Netherlands). (14). 
Data were recorded at a frequency of 200 Hz using ICM+ software (Cambridge 
Enterprise, UK, http://www.neurosurg.cam.ac.uk/icmplus). 
 
The collected data for the study included the following variables: age, gender, 
number of days between the occurrence of the subarachnoid haemorrhage and the 
date of the recording, the fact whether patients were sedated and mechanically 
ventilated or not when the recording was made, the WFNS score upon admission 
(22), the Glasgow score upon admission, the Fisher grade evaluating the importance 
of subarachnoid haemorrhage on initial CT scan, the location of subarachnoid 
haemorrhage, the treatment applied for ruptured aneurysm, the presence of 
hydrocephalus and the presence of an external derivation as well as BRS, the mean 
arterial blood pressure (MAP), and the heart rate (HR) and also ABP variability in the 
low frequency range (LF:0.04-0.15Hz) calculated from systolic ABP. All physiological 
data were calculated from the first recording carried out after admission. 
Subsequently, the occurrence of a documented infection, the occurrence of 
vasospasm as diagnosed on Transcranial Doppler with an increase of mean velocities 
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above 120cm/sec and an increase of the Lindegaard index above 3,  on the middle 
cerebral artery (19), the occurrence of a delayed ischemic deficit (DID), and the 3 
month-Glasgow Outcome Scale score (23) were recorded. 
This protocol was approved by the local Research Ethics Committee. All patients were 
required to sign a written informed consent. In case of lack of capacity the next-of-kin 
was approached. 
 
Outcome measure 
All the patients who survived were evaluated at 3 months after discharge at the 
Addenbrooke’s hospital. The GOS (which classifies patients into 5 categories) was 
evaluated by the treating neurosurgeon (23). 
A good outcome was defined by a GOS equal to 4 or 5. 
 
Calculation of baroreflex sensitivity (BRS) 
The time series used to calculate BRS, systolic blood pressure and the RR intervals, 
were extracted from the recordings made in these patients early after admission. 
Baroreflex sensitivity index was calculated in msec/mmHg using the BRS cross-
correlation method, also referred to as x-BRS, which evaluates the baroreflex in the 
time domain after having adjusted for the variable nature of the delay in variation 
between the systolic ABP (sABP) (the input signal) and the RR interval (the output 
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signal) (24). Comparison of this method with other BRS calculation methods using the 
EUROBAVAR multi-centre database has demonstrated that x-BRS results in a lower 
intra- and inter-individual variability (24). xBRS method has been validated against 
the gold standard of phenylephrine and nitroprusside bolus injections (25). Normal 
values of BRS calculated with the xBRS method from a data set obtained from 21 
patients (4 men and 17 women) aged 20 to 68 (source: EUROBAVAR database) 
yielded a mean value for xBRS of 12.4 msec/mmHg, as compared to 13.4msec/mmHg 
for BRS calculated locally using the sequence method (26) by the team who set the 
method for x-BRS calculation, and compared to 16.2msec/mmHg for BRS calculation 
from the EUROBAVAR database (24). 
The x-BRS calculation algorithm was implemented in ICM+ software and its 
performance was carefully validated against the original software provided by Dr 
Berend Westerhof.  x-BRS calculations were performed using a moving 10sec window 
(moved along the time axis in 10 sec steps), along with mean values of the other vital 
signs variables included in analysis. However, the x-BRS algorithm required sABP and 
RR time series to be incrementally shifted with respect to each other in search of the 
highest value of cross-correlation, which meant that the actual total window length 
used in each x-BRS calculation extended to 17 sec (24). All the analysed physiological 
data were ultimately averaged over each recording.   
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ICM+ permitted also to calculate from the same time series the spectral power of 
ABP in the low frequency range (LF: 0.04-0.15Hz) 
 
Statistical analysis 
Descriptive analysis included absolute (relative) frequencies for categorical variables 
and median (minimum-maximum) for continuous variables. Differences in median 
BRS between groups were investigated by the Mann-Whitney or the Kruskal-Wallis 
test, accordingly to the number of groups, while the null hypothesis of no correlation 
between BRS and an ordinal type variable was examined by the Spearman correlation 
test. 
Associations between the outcome and each studied variable were evaluated by 
simple (with a single explanatory variable) logistic regression models. In accordance 
with the sample size, BRS effect was then adjusted for only one more variable. 
Interaction terms were not allowed. All models of the previous format were 
considered and the choice of the best model was based on the likelihood ratio test 
for nested models and on the Akaike Information Criterion (AIC) otherwise.  In order 
to adequately deal with the situation of having a small number of cases in the class of 
poor outcome, estimation was through maximization of the penalized likelihood as 
introduced by Firth (27). 
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For the models of interest, the area under the ROC (Receiver Operating 
Characteristic)-curve (AUC) was computed. This is a measure of the accuracy 
(discrimination ability) of a model. The threshold value, or cutoff, for BRS was 
determined by the Youden's index, thus maximizing the sum of sensitivity and 
specificity.  
The statistical analyses were performed with the R language and software 
environment for statistical computation, version 2.3.3 (28). The significance level was 
set at 0.05. 
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RESULTS 
 
One hundred and one patients were included in the prospective series. From these 
patients, 4 were under treatment with beta-blockers (exclusion criterion), 47 patients 
were under treatment with noradrenaline (exclusion criterion) and 2 patients had 
recordings that could not be used for BRS calculation because of poor quality ABP 
signal.  
Therefore, the total number of patients for analysis was 48.  Median age was 58 years 
old (36 to 76 years old). The female/male ratio was 34/14. Median of WFNS clinical 
severity score upon admission was 2 (1 to 5). Seven patients were sedated and 
mechanically ventilated, 16 patients had hydrocephalus and 12 patients had external 
derivation. At the time of BRS measurement, 7 patients were treated with 
endovascular coiling, 27 patients were treated with clipping, 2 patients were treated 
with coiling and clipping and 12 patients were not treated yet for the ruptured 
aneurysm at the time of BRS measurement (8 patients) or had conservative 
treatment on the total period of hospitalization (4 patients). 
Median time for BRS measurement from SAH occurrence was 3 days and interquartile 
range was of 2 days. 
In the univariate analysis, BRS (P=0.007), sedation (P=0.001), the WFNS score 
(P=0.001), the Glasgow score (P=0.002), the Fisher score (P=0.022) and heart rate 
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(P=0.037) were significantly associated with outcome. Table 1 indicates the results 
from the univariate analysis evaluating the association between the dichotomized 
outcome assessed by the Glasgow Outcome Scale (GOS), GOS: 4-5 = good 
outcome and GOS 1-3: poor outcome, and the potential explanatory variables 
considered.  
Figure 1 plots the distribution of BRS in each class of the dichotomized GOS. 
We described in Table 2 the potential impact on BRS of the following variables: age, 
sex, WFNS, sedation/mechanical ventilation, site of subarachnoid hemorrhage, 
vasospasm, external derivation and treatment of the aneurysm. 
 
AUC for the model including only BRS as a predictor was 0.835. The model estimated 
an odds ratio (OR) (95%CI) of 1.313 (1.097-1.674), implying an increase of 31% in the 
odds for a good outcome for each unit increase in BRS.  AUC for the model including 
only the heart rate (resp. WFNS) was 0.670 (resp. 0.853) and the predictor was 
statistically significant. 
In a multivariate analysis evaluating the (adjusted) effect of BRS, the best model 
consisted of BRS (OR:1.312[1.048-1.818];P=0.015) and WFNS  (OR:0.382[0.171-0.706]; 
P=0.001) as explanatory variables, and presented an AUC of 0.900. (Figure 2) 
The value of the estimated coefficients and their standard deviations are presented in 
Table 3. 
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The model composed of BRS and heart rate (HR) exhibited a worse performance, with 
a non-significant effect of HR on good outcome (BRS: P=0.049; HR: P= 0.909). 
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                                                              DISCUSSION 
 
After aneurysmal subarachnoid haemorrhage, we have highlighted a significant 
association between BRS and the outcome at 3 months. Each increase of one unit on 
BRS was estimated to raise by 31% the odds for having a good 3-month outcome. This 
result is novel in a context where known data concerning the baroreflex in aneurysmal 
subarachnoid haemorrhage is scarce. 
The consequences of changes in the autonomic nervous system with activation of the 
stress system are however known in this pathology. Particulary so for complications 
related to the activation of the sympathetic system, such as arrhythmia, cardiac 
ischemia, neurogenic pulmonary oedema and Tako Tsubo cardiomyopathy. 
Besides the occurrence of cardiovascular complications, other mechanisms may 
explain the association between decreased BRS and poor outcome, in particular, the 
consequences of increased activity of the sympathetic system which is known to be 
associated with lower BRS (4, 5, 6). Indeed, sympathetic activation is associated with 
increased platelet aggregation, hyperglycaemia, inflammation and increase of the 
blood-brain barrier’s permeability (29). 
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Our results are in line with those of Papaioannou et al. who found in 20 brain injured 
patients from multiple causes, including 3 patients with SAH, an association between 
decreased BRS and a high mortality rate (18). They are also in line with the results   of 
Schmidt et al. (30) who, assessed HR variability in the frequency domain in 
subarachnoid haemorrhage and identified an association between the LF/HF ratio (a 
ratio between the low frequency power and the high frequency power in RR intervals 
time series), which is an indicator of the sympathetic activity, and the occurrence of 
an infection or of a delayed ischemic deficit. In another study, Schmidt et al 
highlighted an association between a HR increase above 95 /minute lasting more 
than 12 hours and the 3-month functional outcome (31). Their results did not include 
the baroreceptor sensitivity assessment. Nonetheless, the sympathetic system 
activation, which includes manifestations such as the HR increase, is known to be 
associated with a lower BRS (4, 5, 6). Our results of lower BRS being associated with 
worse outcome are therefore consistent with the pervious results which indicated an 
association between sympathetic activation and unfavourable outcome after SAH. 
In our study, the adjustment of the HR effect to BRS annihilated the significance of 
HR. The baroreflex, which is a biofeedback loop, integrates a more global information 
than HR increase in response to stress. This can be explained by the fact that, for 
good functioning of the baroreflex arc, the following are required: (1) operational 
afferents which depend on the state of baroreceptors which are known to be altered 
in atheromatous patients (6, 13-16); (2) an operational integration of the signal 
related to the brainstem nuclei which are interconnected with other cortical brain 
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areas, especially insular areas. The severity of the acute brain aggression of 
aneurysmal subarachnoid haemorrhage potentially impairs their functioning by the 
apoptotic mechanisms that it is believed to trigger (32); (3) the efferents which 
control the contractility and rate of the heart muscle, on one hand, and the 
peripheral vasoconstriction, on the other hand. Their action is dependent on the prior 
cardiovascular condition and the systemic complications of the subarachnoid 
haemorrhage which can include impairment of vasomotricity of the peripheral 
vascular bed and also, impairment of cardiac response.  Therefore, lower BRS is likely 
to integrate the following: prior cardiovascular condition, severity of the 
subarachnoid haemorrhage and occurrence of systemic complications during 
hospitalization.  
We did not find a significant association between BRS and vasospasm. As compared 
to our results, the results by Nellgard et al. (17) (published as an abstract) depicted an 
association between initial decrease of BRS, more specifically on day 1, and the 
occurrence of vasospasm. In contrast with our study, Nellgard et al. studied the 
kinetics of BRS to assess their impact on vasospasm. Also, they did not find an 
association between reduced BRS and outcome. However, the number of patients 
studied was relatively small (n=21) and description of medications that could have 
influenced BRS was not available due to the abstract form of the report. 
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Our study included sedated and mechanically ventilated patients in whom the main 
sedation drug used was propofol. This might have influenced the cardiovascular 
autonomic nervous system. However, although propofol was found to inhibit the 
sympathetic nervous activity in reaction to hypotension, it did not modify the 
responsive reflex heart rate variation (33) which is assessed in our study through BRS.  
Mechanical ventilation can be another factor that is able to alter baroreflex 
sensitivity. In a study by Andry Van de Louw et al (34), mechanical ventilation 
attenuated respiratory arrhythmia and was associated with altered BRS sensitivity. In 
our study, we did not find a significant association between mechanical ventilation 
and BRS, which might be due the relatively small number of patients. 
Our study included 48 patients, of which 9 had a poor outcome. This did not allow for 
the adjustment of the BRS effect to several potentially confounding factors 
simultaneously. The relatively small sample is thus the main limitation of our study.   
Another limit is that the data did not encompass information concerning carotid 
atherosclerosis as all acute patients were not screened for carotid atherosclerosis. 
Plaque surface and morphology features as well as localization of atherosclerotic 
plaques are all characteristics that are able to determine different arterial wall 
damages and nerve destruction with a subsequent alteration of BRS. (14-16). 
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The strength of our study is that it has been conducted on a homogeneous 
population in terms of absence of obvious factors known to modify the baroreflex, 
such as the beta-blockers, or factors which may have such an action, as the 
noradrenaline. In the upcoming studies, it will be useful to integrate these patients 
which have not been included in the current series, in order to test the association 
identified between the BRS and the outcome in conditions of usual clinical care, thus 
accepting the limit of pharmacologic factors that may interfere in the assessment of 
the association between BRS and outcome. A confirmation of these results is needed 
in a larger multicenter study. 
The significant association between BRS measured during hospitalization and the 3-
month outcome in our study has been found at an early stage. Should any causality 
elements be acquired based on larger multicenter studies, this would pave the way 
for therapeutic opportunities - pharmacological or non-pharmacological- assessing 
the impact of baroreflex improvement on outcome, in aneurysmal subarachnoid 
haemorrhage. 
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Variables Total (n=48) GOS 1-3 (n=9) GOS 4-5 (n=39) Simple logistic regression 
OR(95%CI)                      P 
BRS   
(msec/mmHg)      
11.7 (1.5-
38.7) 
4.3 (1.5-13.9) 12.6 (3.2-38.7) 1.359 (1.088, 1.698)     0.007 
Age 58 (36-76) 60 (47-74) 57 (36-76) 0.977(0.910, 1.049)      0.521    
Gender 
Female 
Male 
  
34 (70.8) 
14 (29.2) 
  
5 (55.6) 
4 (44.4) 
  
29 (74.4) 
10 (25.6) 
  
1.0 
0.431(0.096, 1.929)     0.271            
WFNS 2 (1-5) 4 (1-5) 1 (1-4) 0.332 (0.154-0.599)      <0.001    
Fisher  (2 cat) 
I (1+2+3) 
II (4) 
  
25 (52.1) 
23 (47.9) 
  
1 (11.1) 
8 (88.9) 
  
24 (61.5) 
15 (38.5) 
  
1.0 
0.078(0.009, 0.688)      0.022 
Sedation 
No 
Yes 
  
41 (85.4) 
7 (14.6) 
  
4 (44.4) 
5 (55.6) 
  
37 (94.9) 
2 (5.1) 
  
1.0 
0.043 (0.006, 0.300)      0.001 
32 
Infection 
No 
Yes 
  
42 (87.5) 
6 (12.5) 
  
7 (77.8) 
2 (22.2) 
  
35 (89.7) 
4 (10.3) 
  
1.0 
0.400(0.061, 2.625)       0.340 
Days from 
admission  
3 (0-10) 2 (1-7) 3 (0-10)  1.084(0.766-1.534)        0.648 
GCS  15 (3-15) 5 (3-13) 15 (8-15) 2.151 (1.324, 3.494)        0.002 
Mean ABP 
(mm Hg) 
128.5 (91.8-
183.5) 
131.6 (118.6- 
183.6) 
128.4 (91.8-
180.5) 
0.979(0.941, 1.018)        0.279 
Heart Rate 
(beats/mn) 
68.0 (44.3-
105.3) 
72.5 (53.9-105.3) 65.97 (44.3-
85.1) 
0.928(0.866, 0.996)         0.037 
  
DID 
no 
yes 
  
36 (75.0) 
12 (25.0) 
  
5 (55.6) 
4 (44.4) 
  
31 (79.5) 
8 (20.5) 
  
1.0 
0.323(0.070, 1.486)           0.147 
Vasospasm 
no 
yes 
 
27 (56.3) 
21 (43.7) 
 
3 (33.3) 
6 (66.7) 
 
24 (61.5) 
15 (38.5) 
 
1.0 
0.312 (0.068, 1.441)          0.136 
ABP-LF 
(mmHg^2) 
6.6 (0.4-
203.7) 
6.9 (1.1-43.8) 2.9 (0.4-203.7) 0.984 (0.960, 1.009)          0.215 
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Table 1: Univariate analysis evaluating the association between a good outcome (GOS 
4 or 5) and the potential explanatory variables considered.  The qualitative variables 
are described by the absolute (relative) frequencies of their categories and the 
quantitative variables are expressed as medians (minimum - maximum). The 
abbreviations used in the table are: GCS: Glasgow coma score; BRS: baroreflex 
sensitivity; ABP: arterial blood pressure; DID: delayed ischemic deficiency. Vasospasm 
refers to mean flow velocity > 120cm/sec on Transcranial Doppler and a Lindegaard 
Ratio > 3.0 on the middle cerebral artery. ABP-LF refers to variability of ABP assessed in 
the frequency domain, and has been calculated as spectral power of ABP in the low 
frequency range (0.04-0.15Hz). The variables significantly associated with 3 month 
outcome were indicated in bold print. 
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  BRS p-value 
Categorical 
Variables 
 Median (min - max)  
Sex Female 11.7 (3.2 – 24.5) 0.867 
 Male 10.6 (1.5 – 38.7)  
Location of SAH Left 10.4 (2.5 – 24.5) 0.152 
 Right 13.6 (2.6 – 38.7)  
 Median 10.9 (1.5 – 18.4)  
Treatment of 
ruptured aneurysm 
at the time of BRS 
measurement 
Not treated 11.5 (2.6 – 24.5) 0.932 
 Coiling 11.3 (1.5 – 14.6)  
 Clipping 10.9 (2.5 – 38.7)  
 Coiling and clipping 12.9 (12.0 – 13.7)  
Sedation and 
mechanical ventilation 
no 12.1 (1.5 – 38.7) 0.314 
 yes 8.7 (2.6 – 13.9)  
Vasospasm on 
transcranial Doppler 
no 12.0 (3.2 – 29.3) 0.885 
 yes 11.3 (1.5 – 38.7)  
35 
External derivation no 12.0 (2.5 – 38.7) 0.408 
 yes 10.5 (1.5 – 13.9)  
Continuous 
Variables 
 Spearman correlation 
coefficient 
p-value 
Age  -0.186 0.206 
WFNS  -0.371 0.015 
 
Table 2 Statistical description of the (univariate) association between BRS and 
variables of interest pertaining to SAH. The Mann-Whitney or the Kruskal-Wallis test 
was used to compare medians across categories; the Spearman correlation coefficient 
and the corresponding test examined the association between BRS and the 
continuous variables.    
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Table 3:  Estimates from the multiple logistic regression model, estimating the 
probability of having a good outcome as a function of BRS and WFNS values. 
  
Variable  Coefficient (Std Error) OR (95% CI)  p-value 
Intercept 1.498 (1.416) ----- ----- 
BRS (ms/mmHg) 0.272 (0.128) 1.312 (1.048 - 1.818) 0.015 
WFNS  -0.961 (0.353) 0.382 (0.171 - 0.706) 0.001 
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Figure 1:   
Distribution of baroreflex sensitivity (BRS) early after admission for poor outcome 
(GOS 1-3) and good outcome (GOS 4-5). 
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Figure 2:  
 
ROC curves for the regression models predicting poor/good outcome from: BRS alone 
(AUC=0.835) in blue color, WFNS alone (AUC=0.853) in green color, and BRS+WFNS in 
black color (AUC=0.900). 
 
